查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2032307

全球植入式心臟整流去顫器（ICD）市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Implantable Cardioverter Defibrillator (ICD) Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 166 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球植入式心臟整流去顫器（ICD）市場預計將從2025年的44.8億美元成長至2034年的81.4億美元，2026年至2034年的複合年成長率（CAGR）為6.86%。這個市場快速擴張的原因在於危及生命的心律不整和心臟麻痹的發生率不斷上升。植入式心臟整流去顫器是一種重要的醫療設備，用於監測心率並在必要時進行電擊以恢復正常功能。人們對心臟健康的日益關注和醫療技術的進步是推動市場成長的主要因素。

技術創新正推動著體積更小、效率更高、使用壽命更長的植入式心臟復律去顫器（ICD）的研發。遠端監測和更先進的診斷功能等特性正在提升患者照護品質。人口老化和醫療成本的不斷上漲進一步促進了市場擴張。醫院和心臟護理中心正擴大採用先進設備來改善治療效果。

未來，ICD市場有望受益於微創手術的進步以及與數位醫療技術的融合。持續的研發將推動更有效率、更人性化的設備的開發。由於心血管疾病仍然是全球關注的重大議題，預計對ICD的需求將穩定成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為深入了解競爭動態和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球植入式心臟整流去顫器(ICD) 市場：依產品類型分類

  • 市場分析、洞察與預測
  • 經靜脈植入式心臟整流去顫器
  • 植入式心臟整流去顫器

第5章 全球植入式心臟整流去顫器（ICD）市場：按類型分類

  • 市場分析、洞察與預測
  • 單腔植入式心律轉復除顫器
  • 雙腔ICD
  • 雙心室裝置

第6章 全球植入式心臟整流去顫器（ICD）市場：以紐約心臟協會（NYHA）分級分類

  • 市場分析、洞察與預測
  • NYHA II級
  • NYHA III級

第7章 全球植入式心臟整流去顫器（ICD）市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 其他

第8章 全球植入式心臟整流去顫器（ICD）市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott
    • Medtronic
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • MicroPort Scientific Corporation
    • LivaNova PLC
簡介目錄
Product Code: VMR112111036

The global implantable cardioverter defibrillator (ICD) market size is expected to reach USD 8.14 Billion in 2034 from USD 4.48 Billion in 2025, growing at a CAGR of 6.86 during 2026-2034.This market is expanding rapidly due to the rising incidence of life-threatening cardiac arrhythmias and sudden cardiac arrest. Implantable cardioverter defibrillators are critical devices that monitor heart rhythms and deliver electrical shocks when necessary to restore normal function. Increasing awareness about cardiac health and advancements in medical technology are key factors driving market growth.

Technological innovations are leading to the development of smaller, more efficient, and longer-lasting ICD devices. Features such as remote monitoring and improved diagnostic capabilities are enhancing patient care. The growing aging population and increasing healthcare expenditure are further supporting market expansion. Hospitals and cardiac care centers are increasingly adopting advanced devices to improve treatment outcomes.

In the future, the ICD market is expected to benefit from advancements in minimally invasive procedures and integration with digital health technologies. Continuous research and development will lead to more efficient and patient-friendly devices. As cardiovascular diseases remain a major global concern, the demand for ICDs is projected to grow steadily.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

  • Transvenous Implantable Cardioverter-Defibrillators
  • Subcutaneous Implantable Cardioverter Defibrillators

By Type

  • Single Chamber ICDs
  • Dual Chamber ICDs
  • Biventricular Devices

By NYHA Class

  • NYHA Class II
  • NYHA Class III

By End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • Abbott, Medtronic, Biotronik SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation., LivaNova PLC

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Transvenous Implantable Cardioverter-Defibrillators Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Subcutaneous Implantable Cardioverter Defibrillators Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Single Chamber ICDs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Dual Chamber ICDs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Biventricular Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET: BY NYHA CLASS 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Nyha Class
  • 6.2. NYHA Class II Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. NYHA Class III Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET: BY END USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End Use
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product Type
    • 8.2.2 By Type
    • 8.2.3 By Nyha Class
    • 8.2.4 By End Use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product Type
    • 8.3.2 By Type
    • 8.3.3 By Nyha Class
    • 8.3.4 By End Use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product Type
    • 8.4.2 By Type
    • 8.4.3 By Nyha Class
    • 8.4.4 By End Use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product Type
    • 8.5.2 By Type
    • 8.5.3 By Nyha Class
    • 8.5.4 By End Use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product Type
    • 8.6.2 By Type
    • 8.6.3 By Nyha Class
    • 8.6.4 By End Use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Abbott
    • 10.2.2 Medtronic
    • 10.2.3 Biotronik SE & Co. KG
    • 10.2.4 Boston Scientific Corporation
    • 10.2.5 MicroPort Scientific Corporation
    • 10.2.6 LivaNova PLC